These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 19679628)

  • 1. False-negative results from point-of-care qualitative human chorionic gonadotropin (hCG) devices caused by excess hCGbeta core fragment vary with device lot number.
    Gronowski AM; Powers M; Stenman UH; Ashby L; Scott MG
    Clin Chem; 2009 Oct; 55(10):1885-6. PubMed ID: 19679628
    [No Abstract]   [Full Text] [Related]  

  • 2. Point-of-care and over-the-counter qualitative human chorionic gonadotropin (hCG) devices remain susceptible to false-negative results caused by excess hCG β core fragment.
    Nerenz RD; Gronowski AM
    Clin Chem; 2013 Nov; 59(11):1672-4. PubMed ID: 23985957
    [No Abstract]   [Full Text] [Related]  

  • 3. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
    Milhorn D; Korpi-Steiner N
    Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterizing urinary hCGβcf patterns during pregnancy.
    Nerenz RD; Yarbrough ML; Stenman UH; Gronowski AM
    Clin Biochem; 2016 Jul; 49(10-11):777-81. PubMed ID: 27087510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-negative results in point-of-care qualitative human chorionic gonadotropin (hCG) devices due to excess hCGbeta core fragment.
    Gronowski AM; Cervinski M; Stenman UH; Woodworth A; Ashby L; Scott MG
    Clin Chem; 2009 Jul; 55(7):1389-94. PubMed ID: 19395437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Performance of Point-of-Care Human Chorionic Gonadotropin Pregnancy Device.
    Farnsworth CW; Nerenz RD; Gronowski AM
    Clin Chem; 2018 Oct; 64(10):1539-1541. PubMed ID: 30068691
    [No Abstract]   [Full Text] [Related]  

  • 7. Falsely decreased human chorionic gonadotropin (hCG) results due to increased concentrations of the free beta subunit and the beta core fragment in quantitative hCG assays.
    Grenache DG; Greene DN; Dighe AS; Fantz CR; Hoefner D; McCudden C; Sokoll L; Wiley CL; Gronowski AM
    Clin Chem; 2010 Dec; 56(12):1839-44. PubMed ID: 20930131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the risk of false negative point-of-care urinary human chorionic gonadotropin device results due to beta core fragment.
    Gronowski AM; Nerenz RD
    Clin Biochem; 2015 Feb; 48(3):97-8. PubMed ID: 25578769
    [No Abstract]   [Full Text] [Related]  

  • 9. Cross-reaction with luteinizing hormone beta-core is responsible for the age-dependent increase of immunoreactive beta-core fragment of human chorionic gonadotropin in women with nonmalignant conditions.
    Iles RK; Javid MK; Gunn LK; Chard T
    Clin Chem; 1999 Apr; 45(4):532-8. PubMed ID: 10102914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the hCGβcf in urine during pregnancy.
    Nerenz RD; Butch AW; Woldemariam GA; Yarbrough ML; Grenache DG; Gronowski AM
    Clin Biochem; 2016 Feb; 49(3):282-6. PubMed ID: 26541857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening method to evaluate point-of-care human chorionic gonadotropin (hCG) devices for susceptibility to the hook effect by hCG β core fragment: evaluation of 11 devices.
    Nerenz RD; Song H; Gronowski AM
    Clin Chem; 2014 Apr; 60(4):667-74. PubMed ID: 24463559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beware of "hook effect" giving false negative pregnancy test on point-of-care kits.
    Yadav YK; Fatima U; Dogra S; Kaushik A
    J Postgrad Med; 2013; 59(2):153-4. PubMed ID: 23793322
    [No Abstract]   [Full Text] [Related]  

  • 13. Discordant results in human chorionic gonadotropin assays.
    Cole LA; Kardana A
    Clin Chem; 1992 Feb; 38(2):263-70. PubMed ID: 1371722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a semi-quantitative pregnancy device for susceptibility to interference caused by hCGβcf.
    Nerenz RD; Butch AW; Ashby L; Woldemariam GA; Gronowski AM
    Clin Biochem; 2015 Aug; 48(12):815-7. PubMed ID: 25916816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in recognition of the 1st WHO international reference reagents for hCG-related isoforms by diagnostic immunoassays for human chorionic gonadotropin.
    Sturgeon CM; Berger P; Bidart JM; Birken S; Burns C; Norman RJ; Stenman UH;
    Clin Chem; 2009 Aug; 55(8):1484-91. PubMed ID: 19541864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Human chorionic gonadotropin beta-core fragment (hCG beta-cf)].
    Okamoto T
    Nihon Rinsho; 1999 Dec; 57 Suppl():586-8. PubMed ID: 10778198
    [No Abstract]   [Full Text] [Related]  

  • 17. Midtrimester urine human chorionic gonadotropin beta-subunit core fragment levels and the subsequent development of pre-eclampsia.
    Bahado-Singh RO; Oz U; Isozaki T; Seli E; Kovanci E; Hsu CD; Cole L
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 1):738-41. PubMed ID: 9757981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diurnal variation of human chorionic gonadotropin beta-core fragment concentrations in urine during second trimester of pregnancy.
    Rotmensch S; Celentano C; Elliger N; Sadan O; Lehman D; Golan A; Glezerman M
    Clin Chem; 2001 Sep; 47(9):1715-7. PubMed ID: 11514413
    [No Abstract]   [Full Text] [Related]  

  • 19. The molar vesicle fluid contains the beta-core fragment of human chorionic gonadotropin.
    Khan S; Katabuchi H; Araki M; Ohba T; Koizumi T; Okamura H; Nishimura R
    Placenta; 2000 Jan; 21(1):79-87. PubMed ID: 10692255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human chorionic gonadotropin beta-core fragment (hCGbetacf)].
    Okamoto T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():765-7. PubMed ID: 16149635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.